Skip to Main Content

Paper Details

Impact of Belimumab on Organ Damage in Systemic Lupus Erythematosus.
Arthritis Care Res (Hoboken)
9
2022
B lymphocyte stimulator, BLyS, Belimumab, SLE, Systemic Lupus, Systemic Lupus Erythematosus, belimumab, lupus nephritis, patients, systemic lupus erythematosus
Author NameAffiliation
Murray B UrowitzToronto Western Hospital
Michelle PetriJohns Hopkins University School of Medicine
  • 1 - 2

Datasets

Release 1.2